Skip to content
Research Article Open access CC BY 4.0

A Case Report on Scleroderma: A Diagnostic Dilema

Ch. K. V. L. S. N. Anjana Male, Hari Chandana Varikallu, Tirumalasetty Sai Swapna, N. Dileep, S. Hemanth Durga Prasad, Sarath Nalla

Journal of Pharmaceutical Research International · pp. 251–255 · Published 6 Aug 2021

10.9734/jpri/2021/v33i40A32241

Abstract

Scleroderma is a rare heterogenous group of autoimmune fibrosing disorder that mainly exists in two forms; localized scleroderma (LS) and systemic sclerosis (SSc). It involves thickening of the skin at fingers region extending from proximal to metacarpophalangeal joints. The diagnostic criteria of scleroderma include past history of patient, symptoms of patient, serology, and skin biopsy. The morbidity and mortality are much worse for SSc with the patients are at risk for life threatening lung, heart and other visceral organ fibrosis and vasculopathy. There is no drug that can cure or stop scleroderma over fibrosis, but certain drugs regulate the symptoms associated with it and boost the patient's quality of life, particularly steroidal creams that help alleviate swelling, joint pain, loosen tight skin; blood pressure drugs that dilate blood vessels; immunosuppressive agents. If the disease is severe amputation is necessary.

Localized scleroderma systemic sclerosis vasculopathy morbidity mortality over fibrosis amputation

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

5

Page views

0

PDF downloads

7

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.